Ledger.Open graph →
SEC Form D · Amendment · filed November 7, 2022

Lanier Biotherapeutics, Inc

Offering
$4.9M
Sold
$3.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOGART, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Daniel White · Bogart, GAExec · Director · PromoterKirby N. Alton · Bogart, GADirectorMartin A. Simonetti · Bogart, GADirectorChristopher N. Mcleod · Bogart, GADirectorJared D. Stanley · Louisville, CODirectorDennis Huffman · Sarasota, FLDirectorAstrid Rodrigues · Hinsdale, ILExec · Director · PromoterJonathan E. Tunnicliffe · Raleigh, NCDirectorLewis A. Scruggs · Bogart, GADirectorGautam Huded · ATLANTA, GADirectorSujoy Gupta · NEW YORK, NYDirectorHerbert Li · NEW YORK, NYDirectorDevin Barnwell · ATLANTA, GAExec · Director · PromoterLewis A. Scruggs · Bogart, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗